Ready to play
Ready to play
A study published in JAMA Network Open showed that GLP-1 medications reduce the risk of serious fractures in elderly patients with type 2 diabetes. The study observed approximately a 21% decrease in fractures caused by minor injuries over three years, with a particular focus on hip, thigh, and spine fractures. Although physicians had feared that the rapid weight loss associated with these drugs might weaken bones, the study demonstrated the opposite effect, although a direct protective mechanism has not yet been proven. Some doctors also warn that these medications could pose risks for patients with amyotrophic lateral sclerosis (ALS) since they rely on rapid weight loss, and they may be associated with increased hair shedding. While the benefits include diabetes and weight management, it is important to weigh the risks and advantages before use.
Notice: This Is an AI-Generated Summary
Comments (0)